This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use



2018 BioCap Conference

Location: Alderley Park Conference Centre, Alderley Park, Cheshire, SK10 4TG

Now in it's seventh year, the BioCap Conference provides a unique meeting place connecting investors, companies who are seeking finance and those who have a track record of raising finance.

BioCap is the only specialist life science investment and showcase conference in the North of England and is aimed at highlighting the wealth of life science investment opportunities.

This one day conference is a great opportunity to meet with potential partners and investors. Helping businesses to realise their full potential, whatever your funding requirements are.

Call For Pitches Competition 
As part of the conference, we will continue to host the popular 'Company Pitching' competition and the submission of applications is now open. Applications are invited from companies who are an established biomedical business and seeking or shortly starting to seek funding of £500k or above. 

The conference will feature sessions on:-

  • Industry Insight Presentations
  • Angel Track: SEIS and EIS Investment Opportunities
  • Tech and Digital Track; What's hot in the digital area
  • Company Pitching Competition
  • Start-up and Pre-start Zone
  • Is acquisition a viable route to success?
  • Partnering meetings

The full conference programme will follow shortly.

We have previously attracted some of the leading life science investors organisations to BioCap including (but not limited to):
Acceleris Capital, Advent Venture Partners, Albion Ventures, Alderley Park Ventures, Amadeus Capital Partners, Amgen, Angel Capital Group, Astellas, AstraZeneca, Bamburgh Capital, Brightstar Partners, Cantor Fitzgerald, Capital Enterprise, Capital Cell, Catapult Ventures, Deepbridge Capital, Diagnostic Capital, Epiphany Capital, Edmond De Rothschild Investment Partners, Enterprise Ventures, Epidarex Capital, EV Group, Foresight Group, Fund, FreeMind Group, Fullbrook Thorpe, Finance Wales, Finance Yorkshire, GM&C Life Sciences, Ignite Capital Partners, Imperial Innovations, InnovateUK, IP Group, Johnson & Johnson Innovation, Kreos Capital, Laidlaw & Company, Liberum, Life Science Biznes Consulting, Longbow Capital, London Stock Exchange, Ludlow Wealth Management, Maven, Medius Associates, Merck Sharpe & Dohme, Mercia Fund Management, Midven, MVM Life Science Partners, Nasdaq, Net Scientific, New Wave Ventures, Northstar Ventures, North West Business Angels, Panmure Gordon, Parkwalk Advisors, Peel Hunt, Pfizer LLC, RBS, Results Healthcare, Scottish Equity Partners, Seroba, Seymour Pierce, Shore Capital, Sixth Element Capital, Spark Impact Ltd, SV Life Sciences, Syncona Investment Management, Syndicate Room, Synergy Health, Tbailey, Takeda Ventures, Takeda TAKcelerator, Torreya Partners, Touchstone Innovations, UKTI VC Unit, Ventac Partners, Wellcome Trust, Wales Business Angels, Warwick Ventures, West Coast Business Angels, Wellcome Trust, WG Partners, Warwick Ventures, WGN, Xenos, Zeus Capital, YFM with more to follow....

Delegate Fees
Premium Member: £125.00 + VAT
Member: £155.00 + VAT
Non-Member: £250.00 + VAT

To discuss the sponsorship and exhibition opportunities available at the conference, please contact Helen Williams at or on 07714 168020.

> Register here